President and COO · Adaptive Biotechnologies Corp · Common Stock
Side
M
Value
$124K
Shares
14.7K
Price
$8.46
Executed
Apr 27, 2026
Disclosed
Apr 29, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 27 executedApr 29, 2026 disclosed
ADPT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+4 / 25
$124K reported value · 3.8% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 26 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rubinstein Julie filed this Form 4 reporting a option exercise of ADPT on Apr 27, 2026. It became public on Apr 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President and COO
Rubinstein Juliecik:0001780664
Issuer
Adaptive Biotechnologies Corpcik:0001478320
Revision history · 0
No field has changed since this record was first ingested.
